Author: Wei-jie Guan; Wen-hua Liang; Yi Zhao; Heng-rui Liang; Zi-sheng Chen; Yi-min Li; Xiao-qing Liu; Ru-chong Chen; Chun-li Tang; Tao Wang; Chun-quan Ou; Li Li; Ping-yan Chen; Ling Sang; Wei Wang; Jian-fu Li; Cai-chen Li; Li-min Ou; Bo Cheng; Shan Xiong; Zheng-yi Ni; Yu Hu; Jie Xiang; Lei Liu; Hong Shan; Chun-liang Lei; Yi-xiang Peng; Li Wei; Yong Liu; Ya-hua Hu; Peng Peng; Jian-ming Wang; Ji-yang Liu; Zhong Chen; Gang Li; Zhi-jian Zheng; Shao-qin Qiu; Jie Luo; Chang-jiang Ye; Shao-yong Zhu; Lin-ling Cheng; Feng Ye; Shi-yue Li; Jin-ping Zheng; Nuo-fu Zhang; Nan-shan Zhong; Jian-xing He
Title: Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis Document date: 2020_2_27
ID: 7s9ot4vq_47
Snippet: Overall, our findings have echoed the recently published studies in terms of the commonness of comorbidities in patients with . Despite considerable variations in the proportion in individual studies due to the limited sample size and the region where patients were managed, circulatory diseases (including hypertension and coronary heart diseases) remained the most . CC-BY-NC-ND 4.0 International license It is made available under a author/funder,.....
Document: Overall, our findings have echoed the recently published studies in terms of the commonness of comorbidities in patients with . Despite considerable variations in the proportion in individual studies due to the limited sample size and the region where patients were managed, circulatory diseases (including hypertension and coronary heart diseases) remained the most . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- cc NC ND International license and coronary heart disease hypertension: 1, 2
- cc NC ND International license and heart disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
- cc NC ND International license and individual study: 1
- cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cc NC ND International license and limited sample size: 1
- circulatory disease and heart disease: 1, 2, 3, 4, 5, 6, 7, 8
- coronary heart disease and heart disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- coronary heart disease and individual study: 1
- coronary heart disease and International license: 1, 2, 3, 4
- coronary heart disease and limited sample size: 1, 2, 3
- coronary heart disease hypertension and heart disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- coronary heart disease hypertension and International license: 1, 2
- coronary heart disease hypertension and limited sample size: 1
- coronary heart disease hypertension include and heart disease: 1
- heart disease and individual study: 1, 2, 3, 4, 5, 6
- heart disease and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- heart disease and limited sample size: 1, 2, 3, 4, 5, 6
- heart disease and patient manage: 1
- individual study and limited sample size: 1
Co phrase search for related documents, hyperlinks ordered by date